POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. Our Privacy Policy
POZ uses cookies to provide necessary website functionality, improve your experience, analyze our traffic and personalize ads. By remaining on our website, you indicate your consent to our Privacy Policy and our Cookie Usage.
allhands
As part of the 11% that are still alive because resistance testing helped navigate treatment options I find this article pretty demeaning. It appears that the big money these days is in PrEP. Big Pharma has a larger demographic to market their overpriced drugs to and by PrEP protocols requiring testing every three months to be on PrEP ASOs are keeping their clinics and pharmacies humming. Resistance testing has helped keep early long term survivors alive.
January 30, 2019